Research Article

You have full text access to this OnlineOpen article

Minocycline is not effective in systemic sclerosis: Results of an open-label multicenter trial

  1. Maureen D. Mayes1,*,
  2. Daniel O'Donnell2,
  3. Naomi F. Rothfield3,
  4. M. E. Csuka4

Article first published online: 5 FEB 2004

DOI: 10.1002/art.20036

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 50, Issue 2, pages 553–557, February 2004

Additional Information

How to Cite

Mayes, M. D., O'Donnell, D., Rothfield, N. F. and Csuka, M. E. (2004), Minocycline is not effective in systemic sclerosis: Results of an open-label multicenter trial. Arthritis & Rheumatism, 50: 553–557. doi: 10.1002/art.20036

Author Information

  1. 1

    University of Texas–Houston Health Science Center

  2. 2

    Wayne State University School of Medicine, Detroit, Michigan

  3. 3

    University of Connecticut, Farmington

  4. 4

    Medical College of Wisconsin, Milwaukee

*Division of Rheumatology and Clinical Immunogenetics, University of Texas–Houston Health Science Center, 6431 Fannin Street, MSB 5.270, Houston, TX 77030

Publication History

  1. Issue published online: 5 FEB 2004
  2. Article first published online: 5 FEB 2004
  3. Manuscript Accepted: 21 OCT 2003
  4. Manuscript Received: 14 JAN 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (61K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Norman T. Ilowite, Ronald M. Laxer, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  2. 2
    Virginia D. Steen, Rheumatology, 2011,

    CrossRef

  3. 3
    B. Maurer, M. Walder, R.E. Gay, S. Gay, O. Distler, Systemische Sklerose, Zeitschrift für Rheumatologie, 2009, 68, 1, 37

    CrossRef

  4. 4
    Suzan M. ATTAR, Tetracyclines: what a rheumatologist needs to know?, International Journal of Rheumatic Diseases, 2009, 12, 2
    Direct Link:
  5. 5
    Svetlana I. Nihtyanova, Christopher P. Denton, Current Approaches to the Management of Early Active Diffuse Scleroderma Skin Disease, Rheumatic Disease Clinics of North America, 2008, 34, 1, 161

    CrossRef

  6. 6
    Dinesh Khanna, Peter A. Merkel, Outcome measures in systemic sclerosis: An update on instruments and current research, Current Rheumatology Reports, 2007, 9, 2, 151

    CrossRef

  7. 7
    O. Nadashkevich, P. Davis, M. Fritzler, W. Kovalenko, A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis, Clinical Rheumatology, 2006, 25, 2, 205

    CrossRef

  8. 8
    Eugene Y. Kissin, Aileen M. Schiller, Rondi B. Gelbard, Jennifer J. Anderson, Vincent Falanga, Robert W. Simms, Joseph H. Korn, Peter A. Merkel, Durometry for the assessment of skin disease in systemic sclerosis, Arthritis Care & Research, 2006, 55, 4
    Direct Link:
  9. 9
    Y. Allanore, A. Kahan, Traitement de la sclérodermie systémique, Annales de Dermatologie et de Vénéréologie, 2006, 133, 3, 286

    CrossRef

  10. 10
    Yannick Allanore, André Kahan, Traitement de la sclérodermie systémique, Revue du Rhumatisme, 2006, 73, 7, 673

    CrossRef

  11. 11
    Yannick Allanore, André Kahan, Treatment of systemic sclerosis, Joint Bone Spine, 2006, 73, 4, 363

    CrossRef

  12. 12
    Melissa I. Costner, Renee H. Grau, Update on Connective Tissue Diseases in Dermatology, Seminars in Cutaneous Medicine and Surgery, 2006, 25, 4, 207

    CrossRef

View Full Article (HTML) Get PDF (61K)